FIELD: biotechnology.
SUBSTANCE: described is a method of treating Alzheimer's disease with a PI4KIIIα inhibitor, which specifically targets PI4KIIIα, wherein said PI4KIIIα inhibitor is selected from one or more inhibitory compounds having a small molecule: radioactive waste, derivatives of radioactive wastes, G1, A1, said RW derivatives contain structures specified in cl. 1 of formula.
EFFECT: invention extends the range of products for treating Alzheimer's disease.
1 cl, 19 dwg, 3 tbl, 18 ex
Authors
Dates
2020-06-23—Published
2016-05-03—Filed